CHIMERIX INC. - COMMO
0.9050
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.0009
+0.10%
Today's range
0.9000 - 0.9395
ISIN
N/A
Source
NASDAQ
-
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
Chimerix Appoints Marc D. Kozin to Board of Directors
21 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Appoints Lisa Decker to Board of Directors
29 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
16 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
03 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
27 Jul 2023 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
27 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
31 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
25 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
04 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
18 Apr 2023 16:01:00 By Nasdaq GlobeNewswire